WithdrawnPhase 4

HCV Post-Exposure Prophylaxis for Health Care Workers

Stopped: No participant enrollment, funding withdrawn.

United States0Started 2019-08-13

Plain-language summary

This is an unblinded, observational trial of sofosbuvir-velpatasvir in adult health care workers who are exposed to hepatitis C virus from needlestick injury with hollow-bore needles.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthcare worker with exposure through needlestick injury with hollow-bore needles to source patients who are HCV positive * Healthcare worker must be HCV Ab- Exclusion Criteria: * HCV Ab positive * HCV Ab negative and HCV RNA greater than 1000 IU/ml * Active malignancy * Positive urine pregnancy test

What they're measuring

Undetectable HCV RNA

Timeframe: 12 weeks post treatment

Trial details

NCT IDNCT03313414

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-01

View on ClinicalTrials.gov More Hepatitis C trials